Granite Investment Partners, LLC Catalent, Inc. Transaction History

Granite Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $5.91 Million - $7.29 Million	-58,212 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $6.27 Million - $7.69 Million	-72,971 Reduced 55.63%	58,212 $6.06 Million
Q3 2020 Nov 06, 2020	SELL	$72.74 - $92.5 $1.1 Million - $1.39 Million	-15,072 Reduced 10.31%	131,183 $11.2 Million
Q2 2020 Aug 03, 2020	BUY	$48.02 - $79.04 $1.94 Million - $3.19 Million	40,356 Added 38.11%	146,255 $10.7 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $3.91 Million - $6.67 Million	105,899 New	105,899 $5.5 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.